Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...
A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast cancer.According ...
Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...
The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...
Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...
ACTIVE monitoring may be a safe and effective treatment option for patients with low-risk ductal carcinoma in situ (DCIS), ...
Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer ...
Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation
For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the ...
B reast cancer is not a single disease but multiple ones, each carrying varying degrees of risk for endangering women’s ...
Two studies suggest that early breast cancer patients can safely avoid specific surgeries, including lymph node removal, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback